Titulo:
Características de las pacientes con cáncer de ovario en el Hospital de San José, Bogotá D.C., 2009-2013
.
Guardado en:
0121-7372
2462-991X
25
2016-03-01
15
21
Fundación Universitaria de Ciencias de la Salud-FUCS - 2016
info:eu-repo/semantics/openAccess
http://purl.org/coar/access_right/c_abf2
| id |
metarevistapublica_fucsalud_revistarepertoriodemedicinaycirugia_98_article_67 |
|---|---|
| record_format |
ojs |
| spelling |
Características de las pacientes con cáncer de ovario en el Hospital de San José, Bogotá D.C., 2009-2013 Mora Padilla, Edmundo Gutiérrez Rodríguez, Everardo Cáncer de ovario Citorreducción Neoadyuvancia Recurrencia Mortalidad Ovarian cancer Cytoreduction Neoadjuvant Recurrence Mortality 25 1 Núm. 1 , Año 2016 : Enero – Marzo Artículo de revista Journal article 2016-03-01 00:00:00 2016-03-01 00:00:00 2016-03-01 application/pdf Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud Revista Repertorio de Medicina y Cirugía 0121-7372 2462-991X https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/67 https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/67 https://creativecommons.org/licenses/by-nc-sa/4.0/ Fundación Universitaria de Ciencias de la Salud-FUCS - 2016 15 21 World Health Organization, International Agency for Research on Cancer. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. [Internet] Ginebra: World Health Organization [citado 10 Feb 2015]. Disponible en: http://globocan., iarc., fr/Default, aspx. Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132:1133–45. Prat J. Oncology FCoG. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2014;124:1–5. MW G. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis. Pathology. 2011;43:420–32. Schorge JO, Modesitt SC, Coleman RL, Cohn DE, Kauff ND, Duska LR, et al. SGO white paper on ovarian cancer: Etiology, screening and surveillance. Gynecol Oncol. 2010;119:7–17. Shih KR. Ovarian tumorigenesis. A proposed model based on morphological and molecular genetic analysis. Am J Pathol. 2004;164:1511–8. Kaye S, Brown R, Gabra H, Gore ME, editores. Emerging therapeutic targets in ovarian cancer. New York: Springer Science; 2011. p. 278. Di Saia PJ, Creasman WT. Clinical gynecologic oncology. Philadelphia, PA: Elsevier; 2007. Heintz AP, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, et al. Carcinoma of the ovary. FIGO 26th Annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95 Suppl 1:S161–92. Tavassoli FA, Devilee P. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IAPS Press; 2003. p. 432. Berek JS, Hacker NF. Berek & Hacker’s gynecologic oncology. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins Health; 2010. Giede KK, Dodge J, Rosen B. Who should operate on patients with ovarian cancer? An evidence-based review. Gynecol Oncol. 2005;99:447–61. Jacobs OD, Faibanks J, Turner J, Frost C, Grudzinskas JG. A risk of malignancy index incorporating ultrasound and menopausal status for the preoperative diagnosis of ovarian cancer. BJOG. 1990;97:922–9. American College of Obstetricians and Gynecologists, Committee on Gynecologic Practice. Committee opinion n. o 477: The role of the obstetrician-gynecologist in the early detection of epithelial ovarian cancer. Obstet Gynecol. 2011;117(3):742-6. Dearking AC, Aletti GD, McGree ME, Weaver AL, Sommerfield MK, Cliby WA. How relevant are ACOG and SGO guidelines for referral of adnexal mass? Obstet Gynecol. 2007;110:841–8. Ueland FR, Desimone CP, Seamon LG, Miller RA, Goodrich S, Podzielinski I, et al. Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors. Obstet Gynecol. 2011;117:1289–97. Galgano MT, Hampton GM, Frierson HF Jr. Comprehensive analysis of HE4 expression in normal and malignant human tissues. Mod Pathol. 2006;19:847–53. Moore RG, McMeekin DS, Brown AK, DiSilvestro P, Miller MC, Allard WJ, et al. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecol Oncol. 2009;112:40–6. Van Gorp T, Cadron I, Despierre E, Daemen A, Leunen K, Amant F, et al. HE4 and CA125 as a diagnostic test in ovarian cancer: Prospective validation of the risk of ovarian malignancy algorithm. Br J Cancer. 2011;104:863–70. Karlsen MA, Sandhu N, Hogdall C, Christensen IJ, Nedergaard L, Lundvall L, et al. Evaluation of HE4. CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass. Gynecol Oncol. 2012;127:379–83. Du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d’Investigateurs Nationaux Pour les Etudes des Cancers de l’Ovaire (GINECO). Cancer. 2009;115:1234–44. Vergote I, Trope CG, Amant F, Kristensen GB, Ehlen T, Johnson N, et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med. 2010;363:943–53. van der Burg ME, van Lent M, Buyse M, Kobierska A, Colombo N, Favalli G, et al. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med. 1995;332:629–34. National Comprehensive Cancer Network. NCCN Guidelines. [Internet] Fort Washington: National Comprehensive Cancer Network [citado 15 Oct 2015]. Disponible en: http://www. nccn.org/professionals/physician gls/f guidelines.asp Titus-Ernstoff L, Perez K, Cramer DW, Harlow BL, Baron JA, Greenberg ER. Menstrual and reproductive factors in relation to ovarian cancer risk. Br J Cancer. 2001;84:714–21. Protani MM, Nagle CM, Webb PM. Obesity and ovarian cancer survival: A systematic review and meta-analysis. Cancer Prev Res (Phila). 2012;5:901–10. Chi DS, Eisenhauer EL, Zivanovic O, Sonoda Y, Abu-Rustum NR, Levine DA, et al. Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecol Oncol. 2009;114:26–31. https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/67/55 info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 http://purl.org/coar/resource_type/c_2df8fbb1 http://purl.org/redcol/resource_type/ART info:eu-repo/semantics/publishedVersion http://purl.org/coar/version/c_970fb48d4fbd8a85 info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 Text Publication |
| institution |
FUNDACIÓN UNIVERSITARIA DE CIENCIA DE LA SALUD |
| thumbnail |
https://nuevo.metarevistas.org/FUNDACIONUNIVERSITARIADECIENCIADELASALUD/logo.png |
| country_str |
Colombia |
| collection |
Revista Repertorio de Medicina y Cirugía |
| title |
Características de las pacientes con cáncer de ovario en el Hospital de San José, Bogotá D.C., 2009-2013 |
| spellingShingle |
Características de las pacientes con cáncer de ovario en el Hospital de San José, Bogotá D.C., 2009-2013 Mora Padilla, Edmundo Gutiérrez Rodríguez, Everardo Cáncer de ovario Citorreducción Neoadyuvancia Recurrencia Mortalidad Ovarian cancer Cytoreduction Neoadjuvant Recurrence Mortality |
| title_short |
Características de las pacientes con cáncer de ovario en el Hospital de San José, Bogotá D.C., 2009-2013 |
| title_full |
Características de las pacientes con cáncer de ovario en el Hospital de San José, Bogotá D.C., 2009-2013 |
| title_fullStr |
Características de las pacientes con cáncer de ovario en el Hospital de San José, Bogotá D.C., 2009-2013 |
| title_full_unstemmed |
Características de las pacientes con cáncer de ovario en el Hospital de San José, Bogotá D.C., 2009-2013 |
| title_sort |
características de las pacientes con cáncer de ovario en el hospital de san josé, bogotá d.c., 2009-2013 |
| author |
Mora Padilla, Edmundo Gutiérrez Rodríguez, Everardo |
| author_facet |
Mora Padilla, Edmundo Gutiérrez Rodríguez, Everardo |
| topic |
Cáncer de ovario Citorreducción Neoadyuvancia Recurrencia Mortalidad Ovarian cancer Cytoreduction Neoadjuvant Recurrence Mortality |
| topic_facet |
Cáncer de ovario Citorreducción Neoadyuvancia Recurrencia Mortalidad Ovarian cancer Cytoreduction Neoadjuvant Recurrence Mortality |
| citationvolume |
25 |
| citationissue |
1 |
| citationedition |
Núm. 1 , Año 2016 : Enero – Marzo |
| publisher |
Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud |
| ispartofjournal |
Revista Repertorio de Medicina y Cirugía |
| source |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/67 |
| language |
|
| format |
Article |
| rights |
https://creativecommons.org/licenses/by-nc-sa/4.0/ Fundación Universitaria de Ciencias de la Salud-FUCS - 2016 info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 |
| type_driver |
info:eu-repo/semantics/article |
| type_coar |
http://purl.org/coar/resource_type/c_6501 |
| type_version |
info:eu-repo/semantics/publishedVersion |
| type_coarversion |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| type_content |
Text |
| publishDate |
2016-03-01 |
| date_accessioned |
2016-03-01 00:00:00 |
| date_available |
2016-03-01 00:00:00 |
| url |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/67 |
| url_doi |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/67 |
| issn |
0121-7372 |
| eissn |
2462-991X |
| citationstartpage |
15 |
| citationendpage |
21 |
| url2_str_mv |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/67/55 |
| _version_ |
1811201474720432128 |